MedPath

Fetal Middle Cerebral Artery (MCA) Doppler to time second and subsequent transfusions for women with red cell alloimmunisation: A randomised trial

Not Applicable
Conditions
Red cell alloimmunisation in pregnancy
Reproductive Health and Childbirth - Fetal medicine and complications of pregnancy
Registration Number
ACTRN12608000643370
Lead Sponsor
The University of Adelaide
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Stopped early
Sex
Female
Target Recruitment
564
Inclusion Criteria

Pregnant women whose fetus has anaemia secondary to red cell alloimmunisation (due to any red cell antibody alone or in combination) as indicated by the need to have performed a single intra-uterine fetal blood transfusion

Exclusion Criteria

Women whose fetus has anaemia secondary to any other cause; known fetal chromosomal anomalies

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cord blood haemoglobin.[Measured in cord blood taken at time of birth.]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath